Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-01 @ 3:32 AM
Study NCT ID:
NCT04036435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-20
First Post:
2019-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-26
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-25
First Submit QC Date:
None
Study First Post Date:
2019-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED